Leslie Trigg

Chief Executive Officer, Outset Medical


Leslie Trigg

Leslie Trigg was previously Outset's Chief Operating Officer and an Executive-in-Residence at Warburg Pincus. Prior to Outset, she was Executive Vice President at Lutonix, a cardiovascular medical device company acquired by CR Bard. Prior to Lutonix, Leslie served as Chief Business Officer of AccessClosure, a vascular closure company acquired by Cardinal Health. Before joining AccessClosure, she was the Vice President, Marketing for FoxHollow Technologies, helping to architect the strategy and commercial infrastructure that led to a successful IPO and subsequent acquisition by ev3/Covidien. Leslie's management experience also includes senior leadership positions at Cytyc Corporation and breast cancer diagnostics company Pro-Duct Health, Inc., which was acquired by Cytyc. She began her medical device career at Guidant Corporation in new product global marketing. Leslie is currently a board member of Cardiovascular Systems, Inc. (NASDAQ: CSII). She received her undergraduate degree from Northwestern University and her MBA from the Haas School of Business, UC Berkeley.

HaasX: Ideas Worth Sharing

Emceed by Kellie McElhaney, Adjunct Associate Professor, Institute for Business & Social Impact and Director, Center for Equity, Gender, & Leadership

The pace will be fast. The ideas will fly. Join an extraordinary group of Berkeley Haas alumni who will, in five minutes or less, share ideas that challenge our assumptions. These speakers conclude the day with presentations that inspire, engage, and provoke conversations that matter.

Twitter @OutsetMedical